Resources
Proteomics Databases
Metabolomics Databases

-
• Serum and Plasma Proteomics for Disease Biomarker Discovery
An application guide to serum and plasma proteomics for disease biomarker discovery, covering matrix choice, discovery limits, candidate narrowing, and separate validation planning.
-
• Why Serum or Plasma Proteomics Results Miss Low-Abundance Proteins
A problem-solving guide explaining why serum and plasma proteomics often miss low-abundance proteins, how to diagnose the cause, and what depth-focused or follow-up paths fit the claim.
-
• Abundant Protein Depletion in Serum and Plasma Proteomics: When Is It Needed?
A decision guide on when abundant protein depletion is needed in serum and plasma proteomics, covering claim dependency, matched chemistry, decision timing, and depth-focused alternatives.
-
• How to Detect Low-Abundance Proteins in Serum and Plasma Proteomics
A practical strategy guide for detecting low-abundance proteins in serum and plasma proteomics, comparing discovery pilots, depth-focused routes, and depletion under matched cohort controls.
-
• Serum, Plasma, and CSF Proteomics: What Researchers Should Know Before Starting
A cost-and-scope planning guide for serum, plasma, and CSF proteomics covering the pre-start decisions that drive project cost, reduce redesign, and keep biofluid comparisons interpretable.
-
• Serum vs. Plasma vs. CSF Proteomics: Which Sample Type Fits Your Study?
An evaluation guide comparing serum, plasma, and CSF for proteomics study fit, covering claim matching, anticoagulant rules, contamination risk, and common matrix mismatches.
-
• Serum/Plasma/CSF Proteomics: How Biofluid Samples Are Analyzed by LC-MS/MS
A deep technical guide to how serum, plasma, and CSF samples are analyzed by LC-MS/MS, covering matrix lock, protein recovery, digestion, acquisition, and report assembly.
-
• Serum/Plasma/CSF Proteomics: What Can LC-MS/MS Actually Detect?
A verification guide explaining what LC-MS/MS can and cannot detect in serum, plasma, and CSF proteomics, including dynamic-range limits, report layers, and realistic coverage expectations.
-
• Can Serum, Plasma, and CSF Proteomics Provide Reliable Protein-Level Data?
A trust-focused guide explaining when serum, plasma, and CSF proteomics can provide reliable protein-level research data, what a complete report includes, and where interpretation limits begin.
-
• Identification-Only vs Quantitative Proteomics for Serum, Plasma, and CSF Samples
A focused comparison of protein identification and quantitative proteomics for serum, plasma, and CSF samples, with a decision guide for biofluid study design.
How to order?
